1
3
Cat. No. | Product Name | Target | Signaling Pathways |
---|---|---|---|
T60753 |
L82
|
DNA | DNA Damage/DNA Repair |
L82 是一种 DNA 连接酶 1 (DNA Lig1) 抑制剂 (hLig1 IC50=12 μM),具有选择性和非竞争性。L82 对乳腺癌细胞表达出抗增殖活性。 |
Cat. No. | Product Name | Species | Expression System |
---|---|---|---|
TMPK-00513 |
LRIG1 Protein, Cynomolgus, Recombinant (His)
Img,LIG1,LIG-1,LRIG1... |
Cynomolgus | HEK293 Cells |
LRIG1 Protein, Cynomolgus, Recombinant (His) is expressed in HEK293 mammalian cells with C-His tag. The predicted molecular weight is 84.16 kDa and the accession number is A0A2K5V8J9. | |||
TMPK-01143 |
LRIG1 Protein, Human, Recombinant (His)
LIG1,Img,LRIG1,LIG-1... |
Human | HEK293 Cells |
LRIG1 Protein, Human, Recombinant (His) is expressed in HEK293 mammalian cells with C-His tag. The predicted molecular weight is 83 kDa and the accession number is Q96JA1-1. | |||
TMPY-02264 |
LRIG1 Protein, Mouse, Recombinant (His)
LIG-1,D6Bwg0781e,leucine-rich rep... |
Mouse | HEK293 Cells |
Leucine-rich repeats and immunoglobulin-like domains 1 (LRIG1) is a tumor suppressor and a negative regulator of several receptor tyrosine kinases. Leucine-rich repeats and immunoglobulin-like domains containing protein 1 (LRIG1) is an endogenous feedback regulator of receptor tyrosine kinases (RTKs) and was recently shown to inhibit the growth of different types of malignancies. Leucine-rich repeats and immunoglobulin-like domains 1(LRIG1)is a kind of transmembrane glycoprotein, which is induce... |